- #1
- 4,777
- 3,837
- TL;DR Summary
- Baylor researchers found that levels of glutathione were statistically lower in Covid patients than controls. Glutathione reduces oxidative stress, low levels were typically seen in 60+ year old healthy patients prior to the pandemic.
If you already kind of understand anti-oxidant effects on inflammation jump past the "background" paragraphs
Background anti-oxidant:
Mitochondria produce energy in the cell, primarily from Krebs cycle (citric acid cycle is another name). Reactive Oxygen Species (ROS) like H2O2 Hydrogen peroxide, are by-products. Glutathione (GSH) is produced in the cytosol of all mammalian cells,
and can also be produced by the liver. Rate limiting of GSH synthesis is beyond the scope of this post, if you want details see:
https://pubmed.ncbi.nlm.nih.gov/18601945/
There are other ROS mop-up molecules but GSH is the bellwether:
GSH mops up the ROS nasties before they damage the cell. This ability declines rapidly in patients over age 60 due to lower GSH levels.
Background oxidative stress due to inflammation:
When ROS molecules hang around because of insufficient levels of mop-up molecules - GSH is major player - cell damage occurs. Damaged cells cause a localized immune system reaction to the problem. The reddened area around an insect bite is localized inflammation.
When the scope of the problem is much larger because of a low systemic level of GSH, entire organ systems can be inflamed. At the highest level this is exemplified by a cytokine storm. Covid damages lung tissue this way.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308649/
Background metabolic disease -
Metabolic disease is a family of pathologies related to oxidative stress: Type II diabetes, atherosclerosis, BMI>=30, waist >39 inches, elevated C-reactive protein (CRP), elevated blood pressure, and a list of other rarer system problems. Heart patients have many of the issues mentioned, for example. I don't believe large segments of Western populations have all of these problems all at once. I hope.
Putting it together:
The Baylor team tested GSH level in Covid patients and found that it was low, indicating oxidative stress. The surprising part was that even young people had low GSH during Covid. They had been doing GSH level testing for several years before Covid. Which made possible the comparison against a control. It was already known that older populations (>60yo) have lower GSH levels than younger ones. Aside: it is possible to use stored sera to test for GSH levels. Correct me if this is wrong.
The implication, of course, is that patients with Covid comorbidities and/or >60 years old, appear to manifest already lower than normal antioxidant serum levels. Before Covid came in and made things a lot worse. More research will continue, but it requires a pre-covid pandemic GSH blood sample. And one during illness or recovery. Not too many places do that kind of test routinely. Or have the necessary stored sera. AFAIK. The UK probably has a better chance of doing larger population testing.
This appears to be very explanatory in terms of why we see the worst problems from Covid where we do:
old people,
comorbidities (pre-existing problems)
Background anti-oxidant:
Mitochondria produce energy in the cell, primarily from Krebs cycle (citric acid cycle is another name). Reactive Oxygen Species (ROS) like H2O2 Hydrogen peroxide, are by-products. Glutathione (GSH) is produced in the cytosol of all mammalian cells,
and can also be produced by the liver. Rate limiting of GSH synthesis is beyond the scope of this post, if you want details see:
https://pubmed.ncbi.nlm.nih.gov/18601945/
There are other ROS mop-up molecules but GSH is the bellwether:
GSH mops up the ROS nasties before they damage the cell. This ability declines rapidly in patients over age 60 due to lower GSH levels.
Background oxidative stress due to inflammation:
When ROS molecules hang around because of insufficient levels of mop-up molecules - GSH is major player - cell damage occurs. Damaged cells cause a localized immune system reaction to the problem. The reddened area around an insect bite is localized inflammation.
When the scope of the problem is much larger because of a low systemic level of GSH, entire organ systems can be inflamed. At the highest level this is exemplified by a cytokine storm. Covid damages lung tissue this way.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308649/
Background metabolic disease -
Metabolic disease is a family of pathologies related to oxidative stress: Type II diabetes, atherosclerosis, BMI>=30, waist >39 inches, elevated C-reactive protein (CRP), elevated blood pressure, and a list of other rarer system problems. Heart patients have many of the issues mentioned, for example. I don't believe large segments of Western populations have all of these problems all at once. I hope.
Putting it together:
The Baylor team tested GSH level in Covid patients and found that it was low, indicating oxidative stress. The surprising part was that even young people had low GSH during Covid. They had been doing GSH level testing for several years before Covid. Which made possible the comparison against a control. It was already known that older populations (>60yo) have lower GSH levels than younger ones. Aside: it is possible to use stored sera to test for GSH levels. Correct me if this is wrong.
The implication, of course, is that patients with Covid comorbidities and/or >60 years old, appear to manifest already lower than normal antioxidant serum levels. Before Covid came in and made things a lot worse. More research will continue, but it requires a pre-covid pandemic GSH blood sample. And one during illness or recovery. Not too many places do that kind of test routinely. Or have the necessary stored sera. AFAIK. The UK probably has a better chance of doing larger population testing.
This appears to be very explanatory in terms of why we see the worst problems from Covid where we do:
old people,
comorbidities (pre-existing problems)
Last edited: